Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation

CMV: a warrior against leukemia?

(2013) P. Ljungman   BLOOD

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

(2013) M. L. Green et al.   BLOOD

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

(2013) V. Beziat et al.   BLOOD

Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function

(2013) Elisa Montaldo et al.   CYTOMETRY PART A

Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device

(2013) Michael Schumm et al.   CYTOTHERAPY

Signatures of Human NK Cell Development and Terminal Differentiation

(2013) Merlin Luetke-Eversloh et al.   Frontiers in Immunology

Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation

(2012) Lena Oevermann et al.   Annals of the New York Academy of Sciences

Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers

(2012) M Stern et al.   BONE MARROW TRANSPLANTATION

Natural killer cell alloreactivity 10 years later

(2012) Andrea Velardi   CURRENT OPINION IN HEMATOLOGY

Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen

(2012) B. Foley et al.   JOURNAL OF IMMUNOLOGY

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

(2011) A. Curti et al.   BLOOD

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

(2011) M. Della Chiesa et al.   BLOOD

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

(2011) B. Foley et al.   BLOOD

G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT

(2011) Y-C Su et al.   BONE MARROW TRANSPLANTATION

CMV drives clonal expansion of NKG2C+NK cells expressing self-specific KIRs in chronic hepatitis patients

(2011) Vivien Béziat et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Human NK receptors: From the molecules to the therapy of high risk leukemias

(2011) Lorenzo Moretta et al.   FEBS LETTERS

Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

(2011) S. Lopez-Verges et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells

(2010) K. Juelke et al.   BLOOD

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

(2010) N. K. Bjorkstrom et al.   BLOOD

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

(2010) S. Lopez-Verges et al.   BLOOD

NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia

(2010) Jeffrey E. Rubnitz et al.   JOURNAL OF CLINICAL ONCOLOGY

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs

(2010) Vivien Béziat et al.   PLoS One

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation

(2009) J. Yu et al.   BLOOD

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets

(2009) J. Yu et al.   BLOOD

Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors

(2009) X-Y Zhao et al.   BONE MARROW TRANSPLANTATION

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation

(2008) L. Vago et al.   BLOOD

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

(2008) D. Pende et al.   BLOOD

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

(2008) F. Ciceri et al.   BLOOD

Human NK cells can control CMV infection in the absence of T cells

(2008) T. W. Kuijpers et al.   BLOOD

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update

(2007) Wolfgang A. Bethge et al.   BLOOD CELLS MOLECULES AND DISEASES